- Diagnosis of HD, confirmed by genetic testing
- Above the age of 18
- A participant (current or newly enrolled) in the Enroll-HD study
- Up to and including stage 2 disease status (TFC 7-13)
Sponsored by
The purpose of this trial is to evaluate whether the around 60 participants (with early manifest HD) who commit to the physical activity program, manage to follow up and complete the 12 month intervention. The active intervention group will be supervised and encouraged by a trainer/physiotherapist on a regular basis. The results on both motor and cognitive tests, will be compared with a group of around 60 participants who are only monitored doing their physical activities as usual. The aim of the study is to see if HD patients, when being followed up and encouraged in a specialized program for physical activity, follow the program and benefit from the training.
Sponsored by
Cardiff University
Countries
Germany
Spain
Number of participants
116 participants
Recruitment status
Recruitment Completed
GERMANY Contact: Not available at the moment Telephone: Not available at the moment Email: Not available at the moment Contact: Not available at the moment Telephone: Not available at the moment Email: Not available at the moment SPAIN Contact: Not available at the moment Telephone: Not available at the moment Email: Not available at the moment Contact: Not available at the moment Telephone: Not available at the moment Email: Not available at the moment Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
TRIAL SITESTrial site: George Huntington Institute Status: [maxbutton id=”3″ ] Address: Münster, Germany, 48149 Trial site: University Hospital Ulm Status: [maxbutton id=”3″ ] Address: Ulm, Germany, 89081 Trial site: Merce de Deu de la Mare Status: [maxbutton id=”3″ ] Address: Barcelona, Spain, 08035 Trial site: Fundacion Jimenez Diaz Status: [maxbutton id=”3″ ] Address: Madrid, Spain, 28040